Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

Sachin Jain, an analyst from Bank of America Securities, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price ...

AstraZeneca did not immediately respond to ... buoyed by robust shopper demand for clothing, toys and beauty products during November and December. Financecategory Carlyle lines up bankers for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Spreading its geographic wings further, in the face of ongoing difficulties in China, UK pharma major AstraZeneca has ...

Whereas the latter derives most of its revenue from a few diabetes or obesity drugs, AstraZeneca has a large and diversified pipeline of medicines. The company's products span the field of ...

AstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been given a consensus recommendation of “Buy” by the ten research firms ...

The drug was previously available through the Cancer Drugs Fund, but with more data, NICE is backing routine access through the NHS.